GARDair.

Sensitizing chemicals may induce sensitization of the respiratory tract, leading to symptoms known as occupational asthma.

GARDair is an in vitro assay in development for predicition of chemical respiratory sensitizers.

There are currently no available method for accurate prediction and classification of chemical respiratory sensitizers. The development of GARDair is the first of its kind, and the research is supported by EU Horizon 2020.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 756014.